Retinitis Pigmentosa (RP) is a degenerative disease that affects the retina’s ability to respond to light, leading to progressive vision loss. Affecting approximately one in every 3,000 people worldwide, it is classified as a rare disease.

RP is hereditary, degenerative, and progressive, with symptoms that may include poor night vision, gradual loss of peripheral vision, and the appearance of pigment deposits in the retina. It is a major cause of visual disability and can lead to total blindness.

In this context, Cuba offers its expertise in diagnosis and a revolutionary treatment to address Retinitis Pigmentosa. The Cuban program is unique in the world, focused on improving the quality of life of those affected.

This singular treatment is designed for individuals who have not completely lost their vision, and it stands out due to a unique surgical technique, combination of therapies, a personalized plan, and the vast experience of a specialized medical team.

The treatment includes revitalizing eye surgery, electrostimulation, ozone therapy, and the use of medications. It is tailored to each patient’s health condition after a comprehensive clinical evaluation to determine eligibility and rule out associated conditions, using state-of-the-art technology.

The service is provided at the Camilo Cienfuegos International Clinic, an institution with extensive experience in ophthalmological care and internationally certified standards.

The results of this therapy are promising, as it helps to control disease progression and enables better visual quality for a longer period compared to untreated patients.

To begin treatment, it is recommended to contact the Coordination and Processing Center of the Cuban Medical Services Trading Company (CSMC, S.A.) via email: 
smc@smcsalud.cu.You will receive detailed information about the medical program and associated costs.

By: MSc. Dr. Patricia Alonso Galbán
Communications Specialist, CSMC, S.A.